News & Updates PRESS RELEASE Maggie Alvarado 6/5/25 PRESS RELEASE Maggie Alvarado 6/5/25 Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders Read More PRESS RELEASE Van Agens 3/12/25 PRESS RELEASE Van Agens 3/12/25 Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business Read More PRESS RELEASE Kyle Kostesich 9/5/23 PRESS RELEASE Kyle Kostesich 9/5/23 Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10 Read More PRESS RELEASE Kyle Kostesich 7/17/23 PRESS RELEASE Kyle Kostesich 7/17/23 Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System Read More PRESS RELEASE Kyle Kostesich 3/21/23 PRESS RELEASE Kyle Kostesich 3/21/23 Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division Read More
PRESS RELEASE Maggie Alvarado 6/5/25 PRESS RELEASE Maggie Alvarado 6/5/25 Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders Read More
PRESS RELEASE Van Agens 3/12/25 PRESS RELEASE Van Agens 3/12/25 Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business Read More
PRESS RELEASE Kyle Kostesich 9/5/23 PRESS RELEASE Kyle Kostesich 9/5/23 Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10 Read More
PRESS RELEASE Kyle Kostesich 7/17/23 PRESS RELEASE Kyle Kostesich 7/17/23 Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System Read More
PRESS RELEASE Kyle Kostesich 3/21/23 PRESS RELEASE Kyle Kostesich 3/21/23 Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division Read More
